W. Hester Visser

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double‐Blind, Single‐Attack Study and Two Open‐Label, Multiple‐Attack Studies

R. Cady, P. Winner, K. Mccarroll, 2004, Headache.

The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss

Erik J. Dasbach, George W. Carides, N. Santanello, 2012, PharmacoEconomics.